Skip to content
value.today

Crescent Biopharma, Inc.: timeline

Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.

86 events

On the market-cap history; source: Market-cap history on value.today.

$72 M$148 M$224 M202120222023202420252026Nov 12, 2026: Results releasedJul 30, 2026: Results releasedJul 16, 2026: 1 insider bought $12.4 million of shares on the marketJul 14, 2026: Results releasedApr 29, 2026: Results releasedFeb 26, 2026: Results releasedFeb 26, 2026: Annual report filed (Form 10-K)Dec 4, 2025: 1 insider bought $18.2 million of shares on the marketNov 6, 2025: Results releasedJul 29, 2025: Results releasedJun 23, 2025: Renamed Crescent Biopharma, Inc.Jun 13, 2025: Results releasedJun 13, 2025: 1-for-100 reverse stock splitJun 13, 2025: Auditor changed; Change in control; Acquisition or sale completedJun 13, 2025: Trading halted on its exchange (D)Feb 13, 2025: Annual report filed (Form 10-K)2025: Record revenue of $11 million2025: Record net income of $0 millionDec 19, 2024: Delisting noticeOct 28, 2024: Change in controlJul 24, 2024: RestructuringJul 24, 2024: Restructuring plan: 26 employeesJun 21, 2024: 2 insiders bought $82,925 of shares on the marketJun 21, 2024: Delisting noticeMay 6, 2024: Results releasedMar 27, 2024: Results releasedNov 3, 2023: Results releasedSep 22, 2023: 1 insider bought $90,256 of shares on the marketAug 2, 2023: Results releasedMay 10, 2023: 2 insiders bought $67,995 of shares on the marketMay 3, 2023: Results releasedMar 29, 2023: Results releasedFeb 24, 2023: 2 insiders bought $3.9 million of shares on the marketJan 26, 2023: 1 insider sold $12.5 million of sharesDec 22, 2022: 1 insider bought $247,500 of shares on the marketNov 17, 2022: 7 insiders bought $484,404 of shares on the marketNov 9, 2022: Results releasedAug 3, 2022: Results releasedApr 28, 2022: Results releasedMar 3, 2022: Results releasedNov 16, 2021: 1 insider bought $82,000 of shares on the marketNov 2, 2021: Results releasedJul 30, 2021: Results releasedMay 3, 2021: Results releasedMar 2, 2021: Results releasedNov 6, 2020: Results releasedNov 4, 2020: 1 insider bought $3.3 million of shares on the marketOct 30, 2020: 1 insider bought $2.6 million of shares on the marketJul 31, 2020: Results releasedMay 1, 2020: Results releasedMar 9, 2020: 1 insider bought $68,000 of shares on the marketFeb 28, 2020: Results released

Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.

  1. 2026

    1. Nov 12, 2026
      Results released

      Form 8-K filed 12 Nov 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Jul 30, 2026
      Results released

      Form 8-K filed 30 Jul 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    3. Jul 16, 2026
      1 insider bought $12.4 million of shares on the market

      Open-market purchases between 16 Jul and 16 Jul 2026

      Insider buying and large selling · source: SEC Forms 4 and 5

    4. Jul 14, 2026
      Results released

      Form 8-K filed 14 Jul 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Apr 29, 2026
      Results released

      Form 8-K filed 29 Apr 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Feb 26, 2026
      Results released

      Form 8-K filed 26 Feb 2026

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    7. Feb 26, 2026
      Annual report filed (Form 10-K)

      For the year to 31 Dec 2025

      Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)

  2. 2025

    1. Dec 4, 2025
      1 insider bought $18.2 million of shares on the market

      Open-market purchases between 04 Dec and 04 Dec 2025

      Insider buying and large selling · source: SEC Forms 4 and 5

    2. Nov 6, 2025
      Results released

      Form 8-K filed 06 Nov 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    3. Jul 29, 2025
      Results released

      Form 8-K filed 31 Jul 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Jun 23, 2025
      Renamed Crescent Biopharma, Inc.

      Formerly Glycomimetics Inc.

      Company history · source: SEC EDGAR

    5. Jun 13, 2025
      Results released

      Form 8-K filed 18 Jun 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Jun 13, 2025
      1-for-100 reverse stock split

      Stock splits · source: SEC filings

    7. Jun 13, 2025
      Auditor changed; Change in control; Acquisition or sale completed

      The company's auditor resigned, was dismissed or a new one was engaged. Control of the company changed hands.

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    8. Jun 13, 2025
      Trading halted on its exchange (D)

      Resumed 16 Jun 2025 04:00 UTC

      Trading halts · source: Nasdaq Trader halt list

    9. Feb 13, 2025
      Annual report filed (Form 10-K)

      For the year to 31 Dec 2024

      Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)

    10. 2025
      Record revenue of $11 million

      FY2025, the highest of the 5 years on record.

      Company history · source: Financial years

    11. 2025
      Record net income of $0 million

      FY2025, the highest profit of the 3 years on record.

      Company history · source: Financial years

  3. 2024

    1. Dec 19, 2024
      Delisting notice

      The exchange told the company it no longer meets a listing rule, or the company is moving or leaving its listing (takeovers are counted separately).

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    2. Oct 28, 2024
      Change in control

      Control of the company changed hands.

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    3. Jul 24, 2024
      Restructuring

      A plan to exit or dispose of activities, usually with job cuts.

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    4. Jul 24, 2024
      Restructuring plan: 26 employees

      In connection with the streamlined operating plan approved by the Board, on July 24, 2024, the authorized officers of the Company committed the Company to a corporate restructuring that includes a red

      Layoffs · source: SEC filing (8-K Item 2.05)

    5. Jun 21, 2024
      2 insiders bought $82,925 of shares on the market

      Open-market purchases between 18 Jun and 21 Jun 2024

      Insider buying and large selling · source: SEC Forms 4 and 5

    6. Jun 21, 2024
      Delisting notice

      The exchange told the company it no longer meets a listing rule, or the company is moving or leaving its listing (takeovers are counted separately).

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    7. May 6, 2024
      Results released

      Form 8-K filed 06 May 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    8. Mar 27, 2024
      Results released

      Form 8-K filed 27 Mar 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  4. 2023

    1. Nov 3, 2023
      Results released

      Form 8-K filed 03 Nov 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Sep 22, 2023
      1 insider bought $90,256 of shares on the market

      Open-market purchases between 21 Sep and 22 Sep 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

    3. Aug 2, 2023
      Results released

      Form 8-K filed 02 Aug 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. May 10, 2023
      2 insiders bought $67,995 of shares on the market

      Open-market purchases between 08 May and 10 May 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

    5. May 3, 2023
      Results released

      Form 8-K filed 03 May 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Mar 29, 2023
      Results released

      Form 8-K filed 29 Mar 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    7. Feb 24, 2023
      2 insiders bought $3.9 million of shares on the market

      Open-market purchases between 09 Feb and 24 Feb 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

    8. Jan 26, 2023
      1 insider sold $12.5 million of shares

      Open-market sales between 03 Jan and 26 Jan 2023

      Insider buying and large selling · source: SEC Forms 4 and 5

  5. 2022

    1. Dec 22, 2022
      1 insider bought $247,500 of shares on the market

      Open-market purchases between 22 Dec and 22 Dec 2022

      Insider buying and large selling · source: SEC Forms 4 and 5

    2. Nov 17, 2022
      7 insiders bought $484,404 of shares on the market

      Open-market purchases between 11 Nov and 17 Nov 2022

      Insider buying and large selling · source: SEC Forms 4 and 5

    3. Nov 9, 2022
      Results released

      Form 8-K filed 09 Nov 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Aug 3, 2022
      Results released

      Form 8-K filed 03 Aug 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Apr 28, 2022
      Results released

      Form 8-K filed 28 Apr 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Mar 3, 2022
      Results released

      Form 8-K filed 03 Mar 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

Share price moves are worked out where the site has the listing's daily prices from the exchange itself: India (NSE), Taiwan (TWSE, TPEx), Brazil (B3), Poland (GPW), Russia (MOEX), Hong Kong (HKEX) and Sri Lanka (CSE). US listings have no daily price source on the site yet.